As an independent student newspaper and the paper of record for the city of Berkeley, the Daily Cal has been communicating important updates during this pandemic. Your support is essential to maintaining this coverage.
The European Patent Office upheld a patent on the CRISPR-Cas9 gene-editing technology following an opposition proceeding that took place from Feb. 5 to Feb. 7.
Read More…
The European Patent Office, or EPO, announced its intentions to grant the University of California a broad patent for CRISPR-Cas9 gene editing technology in late March.
Read More…
